FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Defibtech Recalls Chest Compression Device

Defibtech begins a Class 1 recall of its RMU-2000 ARM XR Chest Compression Devices due to a motor problem that may cause them to stop compressions.

latest-news-card-1
Human Drugs

Wex Pharma Gets Fast Track for Pain Drug

FDA gives Wex Pharmaceuticals a fast-track designation for Halneuron (tetrodotoxin for injection), an alternative to narcotics and opioids for treatin...

latest-news-card-1
Human Drugs

FDA Publishes 68 New, Revised Product-Specific Guides

FDA publishes 68 new and revised product-specific guidances to aid in generic drug development.

latest-news-card-1
Medical Devices

Request for Information Guidance

FDA publishes a guidance on procedures for submitting section 513(g) requests for information on medical device classification.

latest-news-card-1
Human Drugs

Liquidia Sues FDA Over Tyvasos Exclusivity

Liquidia Corp. sues FDA over the agencys recent decision to grant United Therapeutics Corp. an additional three-year exclusivity period for Tyvaso DPI...

latest-news-card-1
Medical Devices

Abbott Labeling Removes Aspirin from Heart Pump

FDA approves an Abbott labeling change on its HeartMate 3 heart pump to eliminate aspirin as part of routine patient management.

latest-news-card-1
Medical Devices

Expos Hits Ethics Conflicts in Shurens Job and Wifes Industry Roles

A New York Times investigative article examines potential conflicts of interest with retiring CDRH director Jeff Shuren and his lawyer wife who repres...

latest-news-card-1
Medical Devices

Medical Device PCCP Guidance

FDA publishes a draft guidance with its current thinking on its policy for medical device predetermined change control plans.

latest-news-card-1
Human Drugs

PhRMA Seeks Changes in Bio Interchangeability Guidance

PhRMA calls on FDA to make changes to a draft guidance on demonstrating biologic interchangeability with a reference product.

latest-news-card-1
Human Drugs

3rd Party Inspection Findings Hits Regeneron BLA

An FDA inspection at a third-party manufacturer cites inspection issues that have resulted in a complete response letter on a Regneron BLA for a multi...